Literature DB >> 25888341

Lung allocation score and health-related quality of life in Japanese candidates for lung transplantation.

Fengshi Chen1, Toru Oga2, Tetsu Yamada1, Masaaki Sato1, Akihiro Aoyama1, Kazuo Chin2, Hiroshi Date3.   

Abstract

OBJECTIVES: The lung allocation score (LAS) system has been implemented to reduce waiting list time and mortality in the USA, but it remains uncertain how the LAS would reflect the impairment in health-related quality of life (HRQOL), which is another lung transplantation treatment goal to be improved in addition to survival. We thus investigated the relationships of the LAS with mortality and HRQOL in Japanese lung transplantation candidates.
METHODS: One hundred and two candidates for lung transplantation at Kyoto University Hospital between 2009 and 2013 were consecutively recruited to participate in this study. Their physiological measurements of pulmonary function and 6-min walking distance, as well as patient-reported measurements of HRQOL, dyspnoea and psychological status, were assessed.
RESULTS: Among these 102 patients, 22 died during a mean follow-up of 11.6 months. The LAS was significantly correlated to mortality (P = 0.0026), although other physiological measurements were not. However, regarding its relationship with HRQOL, correlation coefficients between the LAS, Medical Outcomes Study 36-item short form and St George's Respiratory Questionnaire (SGRQ) were relatively low, with the highest at 0.31. Multivariate analyses showed that the LAS was less significantly related to the SGRQ total score than dyspnoea, and psychological status.
CONCLUSIONS: The LAS was significantly related to mortality in lung transplant candidates in Japan, while, despite its multidimensional scoring, its relationship with health-related quality of life was only weak. Their severity assessment system may be more focused on patients' health and symptoms.
© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Chronic respiratory failure; Health-related quality of life; Lung allocation score; Lung transplantation; Pulmonary function

Mesh:

Year:  2015        PMID: 25888341     DOI: 10.1093/icvts/ivv101

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  5 in total

1.  Severe underweight decreases the survival rate in adult lung transplantation.

Authors:  Teruya Komatsu; Toyofumi F Chen-Yoshikawa; Ayako Oshima; Shin-Ichi Harashima; Akihiro Aoyama; Nobuya Inagaki; Hiroshi Date
Journal:  Surg Today       Date:  2017-03-17       Impact factor: 2.549

2.  Physical activity level significantly affects the survival of patients with end-stage lung disease on a waiting list for lung transplantation.

Authors:  Teruya Komatsu; Ayako Oshima; Toyofumi F Chen-Yoshikawa; Shin-Ichi Harashima; Akihiro Aoyama; Nobuya Inagaki; Hiroshi Date
Journal:  Surg Today       Date:  2017-05-24       Impact factor: 2.549

3.  Patient-reported dyspnea and health predict waitlist mortality in patients waiting for lung transplantation in Japan.

Authors:  Masaki Ikeda; Toru Oga; Toyofumi F Chen-Yoshikawa; Junko Tokuno; Takahiro Oto; Tomoyo Okawa; Yoshinori Okada; Miki Akiba; Satona Tanaka; Yoshito Yamada; Yojiro Yutaka; Akihiro Ohsumi; Daisuke Nakajima; Masatsugu Hamaji; Maki Isomi; Kazuo Chin; Hiroshi Date
Journal:  Respir Res       Date:  2021-04-21

Review 4.  Relationship of Exercise Capacity, Physical Function, and Frailty Measures With Clinical Outcomes and Healthcare Utilization in Lung Transplantation: A Scoping Review.

Authors:  Nicholas Bourgeois; Shirin M Shallwani; Fahad S Al-Huda; Sunita Mathur; Charles Poirier; Tania Janaudis-Ferreira
Journal:  Transplant Direct       Date:  2022-10-07

5.  Analysis of Optimal Health-Related Quality of Life Measures in Patients Waitlisted for Lung Transplantation.

Authors:  Junko Tokuno; Toyofumi F Chen-Yoshikawa; Toru Oga; Takahiro Oto; Tomoyo Okawa; Yoshinori Okada; Miki Akiba; Masaki Ikeda; Daisuke Nakajima; Masatsugu Hamaji; Hideki Motoyama; Akihiro Aoyama; Maki Isomi; Kazuo Chin; Hiroshi Date
Journal:  Can Respir J       Date:  2020-03-05       Impact factor: 2.409

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.